“ivacaftor” Archives

in
Entry Author Date Location
Vertex Stock Up on Quick FDA OK For 3-Drug Cystic Fibrosis Therapy 10/22/19 Boston
Vertex Selects Drug Combo, a Potential Therapy for 90% of CF Patients 05/30/19 Boston
Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3 03/06/19 Boston
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Vertex Hits Again in CF as First Three-Drug Combo Succeeds in Phase 3 11/27/18 Boston
Vertex CF Competitor Proteostasis Falters, Galapagos Up Next 06/07/18 Boston
Vertex Pharma Gets FDA Approval for Combo CF Drug, Sets $292,000 Price 02/12/18 Boston
Vertex Touts Positive Triple-Drug Data For Cystic Fibrosis Patients 07/18/17 Boston
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
With New Data, Vertex Touts Backbone Of Future Cystic Fibrosis Drugs 03/28/17 Boston
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More 03/10/16 Boston
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
At Duchenne Panel, Parents Plead With Experts, FDA Decision Looms 11/24/15 San Francisco
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Small Molecules: The Silent Majority of Pharmaceutical Pipelines 11/23/15 Boston
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis 07/02/15 Boston
Vertex Teams up With Durham’s Parion in $80M Lung Drug Deal 06/04/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
FDA Panel Backs Vertex’s Two-Drug Combo For Cystic Fibrosis 05/12/15 Boston
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Crowdfunding is Banging on Biotech’s Door. Will We Let It In? 01/21/15 Boston
Page 1 of 2 next page »